SEC 13F Intelligence

Gabelli & Co Investment Advisers, Inc. / AMED

Gabelli & Co Investment Advisers, Inc.’s Amedisys Inc Position

Does Gabelli & Co Investment Advisers, Inc. own Amedisys Inc (AMED)? Not currently — the last reported position was 224.4K shares worth $22M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$22M
Q2 2025
Shares
224.4K
% of Portfolio
+3.39%
Quarters Held
9
position exited

Position History AMED

Reported value by quarter
Q2 ’23: $3MQ2 ’23Q3 ’23: $15MQ4 ’23: $19MQ4 ’23Q1 ’24: $18MQ2 ’24: $19MQ2 ’24Q3 ’24: $19MQ4 ’24: $17MQ4 ’24Q1 ’25: $18MQ2 ’25: $22MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025224.4K$22M+3.39%
Q1 2025197.5K$18M+2.77%
Q4 2024192.4K$17M+2.98%
Q3 2024200.7K$19M+3.30%
Q2 2024204.4K$19M+3.13%
Q1 2024196.8K$18M+3.16%
Q4 2023201.5K$19M+3.59%
Q3 2023163.0K$15M+2.48%
Q2 202332.3K$3M+0.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gabelli & Co Investment Advisers, Inc.’s full portfolio or all institutional holders of AMED.